blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0464206

EP0464206 - DRUG FOR IMPROVING BRAIN FUNCTION [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  23.02.1996
Database last updated on 24.08.2024
Most recent event   Tooltip23.02.1996Refusal of applicationpublished on 10.04.1996 [1996/15]
Applicant(s)For all designated states
DAIICHI PHARMACEUTICAL CO., LTD.
14-10, Nihonbashi 3-chome Chuo-ku
Tokyo 103 / JP
[N/P]
Former [1992/02]For all designated states
DAIICHI PHARMACEUTICAL CO., LTD.
14-10, Nihonbashi 3-chome
Chuo-ku, Tokyo 103 / JP
Inventor(s)01 / KITAOKA, Hirofumi 14-21, Nankodai 5-chome
Izumi-ku
Sendai-shi Miyagi 981 / JP
02 / KAWAJIRI, Shinichi Daiichi Pharmaceutical Co.
Ltd. Research Institute 16-13, Kitakasai
1-chome Edogawa-Ku Tokyo 134 / JP
[1992/02]
Representative(s)Kinzebach, Werner, et al
Reitstötter, Kinzebach & Partner Patentanwälte Postfach 86 06 49
81633 München / DE
[N/P]
Former [1992/02]Kinzebach, Werner, Dr., et al
Patentanwälte Reitstötter, Kinzebach und Partner Postfach 86 06 49
D-81633 München / DE
Application number, filing date90904947.023.03.1990
[1992/02]
WO1990JP00392
Priority number, dateJP1989007237124.03.1989         Original published format: JP 7237189
[1992/02]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9011080
Date:04.10.1990
Language:EN
[1990/23]
Type: A1 Application with search report 
No.:EP0464206
Date:08.01.1992
Language:EN
The application published by WIPO in one of the EPO official languages on 04.10.1990 takes the place of the publication of the European patent application.
[1992/02]
Search report(s)International search report - published on:JP04.10.1990
(Supplementary) European search report - dispatched on:EP25.03.1992
ClassificationIPC:A61K31/70, // C07H19/213
[1992/02]
CPC:
A61K31/70 (EP); C07H19/20 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1992/02]
TitleGerman:HEILMITTEL ZUR STEIGERUNG DER GEHIRNFUNKTION[1992/02]
English:DRUG FOR IMPROVING BRAIN FUNCTION[1992/02]
French:MEDICAMENT AMELIORANT LES FONCTIONS CEREBRALES[1992/02]
File destroyed:20.04.2002
Entry into regional phase23.09.1991Translation filed 
23.09.1991National basic fee paid 
23.09.1991Search fee paid 
23.09.1991Designation fee(s) paid 
22.11.1991Examination fee paid 
Examination procedure24.10.1990Request for preliminary examination filed
International Preliminary Examining Authority: DE
22.11.1991Examination requested  [1992/09]
02.03.1994Despatch of a communication from the examining division (Time limit: M06)
14.10.1994Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
23.12.1994Reply to a communication from the examining division
30.03.1995Despatch of communication of intention to grant (Approval: )
10.11.1995Despatch of communication that the application is refused, reason: formalities examination [1996/15]
20.11.1995Application refused, date of legal effect [1996/15]
Request for further processing for:23.12.1994Request for further processing filed
23.12.1994Full payment received (date of receipt of payment)
Request granted
24.01.1995Decision despatched
Fees paidRenewal fee
31.03.1992Renewal fee patent year 03
25.03.1993Renewal fee patent year 04
31.03.1994Renewal fee patent year 05
31.03.1995Renewal fee patent year 06
Penalty fee
Penalty fee Rule 85b EPC 1973
22.11.1991M01   Fee paid on   22.11.1991
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]DE2326600  ;
 [Y]US4058659  ;
 [A]FR2184813  ;
 [AP]EP0355899  ;
 [X]EP0249873
 [X]  - JOURNAL OF NEUROSURGERY, vol. 39, no. 6, December 1973, pages 730-734; E.W. PETERSON et al.: "The reversal of experimental vasospasm by dibutyryl-3', 5'-adenosine monophosphate"
 [X]  - PSYCHOPHARMACOLOGY, vol. 90, no. 4, 1986, pages 430-435; H. WACHTEL et al.: "Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram"
 [X]  - LIFE SCIENCES, vol. 12, no. 8, 15th April 1973, pages 345-356; M. WEINER et al.: "The behavioral effects of dibutyryl cyclic AMP in Mice"
 [Y]  - NEUROLOGY, vol. 36, no. 1, January 1986, pages 89-92; L. VOLICER et al.: "CSF cyclic nucleotides and somatostatin in Parkinson's disease"
 [Y]  - ARCHIVES OF NEUROLOGY, vol. 32, no. 8, August 1975, pages 569-571; E.S. FLAMM et al.: "Phosphodiesterase inhibitors and cerebral vasospasm"
International search[A]JPS52156935  ;
 [A]JPS62252726
 [A]  - CHEMICAL ABSTRACTS, Vol 109 (No.25): 221676w, 1988 & Acta Med. Rom., 26(1), p.52-5, 1988.
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.